Business Valuations under AKS and Stark Law with Richard Romero from Coker Group

Episode Date: March 23, 2022

In this episode of Stark Integrity, host Bob Wade (“Captain Integrity”) is joined by Richard Romero of Coker to explore a critical topic at the intersection of compliance and finance: business valuations under the Stark Law and the Anti-Kickback Statute (AKS).

While fair market value (FMV) is often discussed in the context of compensation, this episode expands the conversation to entity-level valuations—where the stakes can be even higher.

Why Business Valuations Matter

When healthcare organizations buy, sell, or invest in businesses—such as physician practices, service lines, or joint ventures—those transactions must reflect fair market value and comply with both Stark Law and AKS requirements.

If valuations are inflated or unsupported, regulators may view the transaction as a vehicle to reward or induce referrals, creating significant legal risk.

Stark Law vs. AKS: Two Lenses

This episode highlights the importance of analyzing valuations under both frameworks:

• Stark Law focuses on whether the valuation reflects FMV and avoids taking into account the volume or value of referrals
• AKS focuses on intent—whether the transaction is designed to induce or reward referrals

Even if a valuation appears compliant under Stark, it may still raise concerns under the AKS if the underlying purpose is questionable.

Key Components of a Defensible Valuation

Bob and Richard emphasize that successful valuations are not just about the final number—they are about methodology and support.

A defensible valuation should include:

• Reliable financial data
• Appropriate valuation methodologies (income, market, or asset approaches)
• Clear assumptions and inputs
• Independent and objective analysis

Without these elements, valuations can be difficult to defend under regulatory scrutiny.

Common Risk Areas

This episode highlights several areas where business valuation issues commonly arise:

Physician Practice Acquisitions

Overpaying for a physician practice—especially where referrals are expected—can be viewed as a disguised payment for future business.

Joint Ventures

Structuring ownership percentages or buy-in terms that do not reflect true FMV can raise concerns about preferential treatment tied to referral potential.

Goodwill and Intangible Value

Assigning excessive value to intangible assets such as goodwill may be questioned if it appears driven by anticipated referral streams.

The Importance of Independence

A key takeaway from this episode is the value of independent, third-party valuation experts.

Independent valuations help:

• Provide objective support for transaction terms
• Reduce bias in the analysis
• Strengthen defensibility in the event of audit or investigation

Relying solely on internal assumptions or unsupported estimates can create unnecessary risk.

Practical Takeaways

The central takeaway is that business valuations must be both accurate and defensible. Healthcare organizations should:

• Engage qualified valuation professionals
• Ensure methodologies are consistent with industry standards
• Document assumptions and conclusions thoroughly
• Evaluate transactions under both Stark Law and AKS frameworks

These steps help ensure that transactions are structured appropriately and can withstand scrutiny.

Final Thoughts

This episode reinforces that business valuations are a critical component of healthcare compliance. Transactions involving physician relationships carry inherent risk—and valuation is often where that risk is evaluated.

By focusing on defensibility, independence, and sound methodology, organizations can pursue strategic opportunities while maintaining strong compliance standards.

In the Stark and AKS environment, a well-supported valuation is not just good business—it’s essential protection.

Click here to listen to this Stark Integrity Podcast Episode:
https://podcasts.apple.com/us/podcast/business-valuations-under-aks-and-stark-law-with/id1588939373?i=1000554165080&l=fr-FR